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ABSTRACT
Background: Delay or failure to view test results in a hospital setting can lead to delayed diagnosis, risk of pa-
tient harm, and represents inefficiency. Factors influencing this were investigated to identify how timeliness
and completeness of test review could be improved through an evidence-based redesign of the use of clinical
test review software.
Methods: A cross-section of all abnormal hematology and biochemistry results which were published on a digi-
tal test review platform over a 3-year period were investigated. The time it took for clinicians to view these
results, and the results that were not viewed within 30 days, were analyzed relative to time of the week, the de-
tailed type of test, and an indicator of patient record data quality.
Results: The majority of results were viewed within 90 min, and 93.9% of these results viewed on the digital
platform within 30 days. There was significant variation in results review throughout the week, shown to be due
to an interplay between technical and clinical workflow factors. Routine results were less likely to be reviewed,
as were those with patient record data quality issues.
Conclusion: The evidence suggests that test result review would be improved by stream-lining access to the re-
sult platform, differentiating between urgent and routine results, improving handover of responsibility for result
review, and improving search for temporary patient records. Altering the timing of phlebotomy rounds and a re-
view of the appropriateness of routine test requests at the weekend may also improve result review rates.
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INTRODUCTION
Large numbers of tests are undertaken in hospitals, and many health-
care professionals are involved in the care of a patient from admission
to discharge. There is evidence that some test results will never be
reviewed, or if reviewed, never followed up on, in both primary and
secondary care.1–3 Estimates of the frequency of the failure to follow-
up on test results are very variable, depending on setting,2,4,5 and the
measurement methodology, but thought to occur somewhere between
1% and 22.9% of inpatient admissions,1 and this is more frequent
where there is a transfer of care between care settings. Other studies
(summarized by Callen et al2) found even wider variation, with inap-
propriate or incomplete follow-up for 6.8% of abnormal test result
alerts in 1 study, to 62% of abnormal glucose screening tests results in
another study. This variability is in part due to differences in clinical
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context, but also the exact nature of the definition of follow-up in
these studies. Missed test results are found to be particularly problematic
if there are test results which are pending after a patient is dis-
charged.6–10 The failure to review test results represents not only a
certain degree of inefficiency, but also a potential clinical safety issue
resulting in missed or delayed diagnoses,1 for example, being a con-
tributory cause for delayed diagnosis and treatment of lung cancer,
and hepatitis C, among others.6,11
Investigations into the introduction of a mandatory test result ac-
knowledgement system in a maternity unit in Australia12 showed a
wide variation in the length of time it took for clinicians to review
and acknowledge test results. They found that the mean time it took
for a newly available blood test result to be viewed was 19.1 h, but
the median was just 3 h, whereas radiology results were reviewed on
average 47.7 h after being published, with a median of 20.8 h,12 sug-
gesting that the distribution of time to view is heavily skewed. This
variability can also contribute to a delay in diagnosis, and therefore
action, as clinicians must first become aware of the abnormal result.
The effect of directly alerting clinicians to abnormal pathology test
results has been investigated in different studies9,13,14 and, taken to-
gether, a reduction in the length of time taken for initiation of cor-
rective therapy was seen, by reducing the delay before the clinician
becomes aware of an abnormal result, or by making the clinician
aware of abnormal results after the patient has gone home.7,9
This article describes a retrospective cross-sectional study of the
clinical use of electronic pathology result review software in Taun-
ton and Somerset NHS Foundation Trust (TSFT). This aims to de-
scribe the people, process and technology factors found to influence
both the timeliness and the completeness of clinical review of test
results. The study focused on a set of test results for which the over-
all completeness of review of test results is broadly in line with re-
search above,2 but with a focus on how this is affected by different
system and workflow factors. The purpose of this is to identify how
timeliness and completeness of test review could be improved
through an evidence-based redesign of the use of clinical test review
software within clinical workflow. This is relevant to people who
design or implement software for pathology test review in a hospital
setting. This study also serves as a baseline for assessing future
changes to the software for pathology result review in TSFT.
The purpose of this article was not to determine the clinical sig-
nificance of delays or failure to view test results, as there are numer-
ous factors that affect clinical outcome that are not controlled for in
this study, not least being that viewing a test result does not neces-
sarily imply that an action has been taken as a result.
METHODS
Setting
The study was conducted on clinical tests from inpatients in Musgrove
Park Hospital, which is part of TSFT. It is a district general hospital,
providing care to a population of over 340 000. It also provides some
specialist services for the whole of Somerset, making the catchment pop-
ulation around 544 000. The hospital has over 700 beds, 30 wards, 15
operating theaters, a fully equipped diagnostic imaging department, and
a purpose-built cancer treatment center.15 TSFT shares its pathology
services with all the hospitals and primary care providers in Somerset.
Information governance
The data required for this audit are routinely automatically collected
as part of the pathology viewer software audit log. The data were
fully de-identified at source before being analyzed by TSFT staff on
computers within the hospital’s secure data center. As an internal
audit of TSFT operations using nonidentifiable data it did not re-
quire patient consent. It was reviewed and approved by the hospital
research and development office and Caldicott guardian (informa-
tion governance lead). No patient identifiable information was
retained by the data extraction.
Dataset
When a result is directly viewed on the system, the pathology viewer
software records the time that the result was accessed in an audit
log. There is also an indirect method for viewing test results in a
timeline-based “grid view,” in which all of the most recent results
are presented simultaneously. This indirect method of viewing
results is also logged by the system, but not at the individual test
result level. Based on feedback from clinical users of the system, the
assumption was made that clinical review of results using the grid
view is equivalent to the direct review of all test results released in
the preceding 24 h.
The source database integrates results from many laboratories, and
radiology departments, stemming from requests from many primary
and secondary care providers. As such the data quality of patient
records has issues, particularly in terms of the creation of temporary
duplicate patient records which require subsequent merging. Such
records may be created if a patient’s contact details have changed or
are miskeyed, or if a patient is admitted in an emergency where incom-
plete demographic details are available. During this subsequent merg-
ing process test results are reassigned to the canonical patient identifier
when possible. Prior to the merge, test results filed under temporary
patient record may be less easy to find than those correctly filed from
the outset. Record merging may happen before, during, or after results
become available on the system, but the results are only reassigned af-
ter they have been published. The reassignment of a test during this
merge process was extracted as an experimental variable and is an in-
dicator of the initial data quality of the patient record.
Selection criteria and study size
The existing laboratory results viewer system contains results from
the last 10 years for the whole of Somerset, involving inpatients and
outpatients over multiple hospital sites and primary care providers.
These were limited to tests that had been requested from inpatient
wards, and emergency ambulatory care in TSFT between September
1, 2014, and September 30, 2017, during which no major changes
occurred in either the test requesting and review processes, or in the
laboratory test result review platform itself. The set was constrained
to the 1 770 775 million biochemistry and hematology reports that
were reported as abnormal on the system, and for these results, there
were no missing data items. Abnormal results are visible as such on
the test review system and such abnormal results represent investiga-
tions that should have clinician review. Finally, unlike radiology
reports which are available on the picture archive and communica-
tions platform, biochemistry and hematology test results are only
available digitally through the results review platform. They are less
widely reviewed via paper reports in TSFT than microbiology, as the
paper reports are only distributed some hours after the digital report
is available. This delay makes the paper hematology and biochemis-
try reports less clinically useful than digital reports, but not so for
microbiology given the longer turn-around times associated with
cultures, and comparatively more telephone alerting of clinicians to
abnormal results.








iaopen/ooaa003/5808994 by guest on 31 M
arch 2020
Data analysis
Dependent and experimental variables were extracted from the source
database using a custom structured query language routine. The main
dependent variables investigated were the time for the first clinician to
view a test result after it becomes available on the system (time to
view) and the proportion of tests which were not digitally viewed on
the pathology results viewing system within 30 days (unviewed tests)
which included 99.9% of all test views. These outcomes are described
in Figure 1. Qualitatively the timeliness of test review is related to the
overall distribution of the time to view, but is essentially quantified
here as the median of the time to view all the tests in a given sample
(Timeliness¼median of time to view a test result). Completeness of
test result review for a given sample can be quantified as the comple-
ment of the unviewed tests (Completeness¼1Number of tests
results not viewed/Total number of test results). Test results were
described at the level of the clinically ordered test battery, so this study
regards the combined test of “Full Blood Count” as a single test,
rather than the individual component “Hemoglobin level.” Only the
most up to date revision of a test result was included.
The study stratified the sample by a number of different experi-
mental variables and visualized the differences in time to view and
percentage of test unviewed after 30 days by these experimental var-
iables. Among many other factors considered as experimental varia-
bles, we report here on temporal variation, the detailed test type of
the result, and the test reassignment status as defined above. Tempo-
ral variation was investigated using the time within the week when
the test result was published as an experimental variable and it was
hypothesized that tests may be reviewed less quickly when staffing
levels are lower overnight, or during the weekend. The detailed type
of test result was selected as clinical tests have different clinical
impacts and it was expected that some test types will be monitored
more closely by clinicians. Test reassignment was investigated as a
marker of data quality of the patient record. It is expected that reas-
signment of tests to different patient identifiers are a proxy measure
for the ease with which clinicians find test results, and hence would
be related to how many results are missed.
All data were analyzed and visualized using R.16 Correlation
strengths are estimated with Cramer’s V coefficient16 and Pairwise
Wilcoxon tests.17 Distributions of time to view were compared with
Kruskal–Wallis tests.18 Instantaneous publish and view rates were
calculated using piecewise polynomial fitting to cumulative rates us-
ing a Savitzky–Golay filter.18 Continuous distributions of median
time to view were calculated from a rolling 2 h window, and error
estimates median time to view estimated using case resampling boot-
strapping.17 Estimates of error in unviewed tests were determined
by the size of the group, assuming a binomial distribution.
RESULTS
Sample characteristics
There were 1770775 abnormal biochemistry and hematology test
results released during the study period (approximately 1600 per day).
Figure 2 shows the difference in daily test result rates between weekdays
and weekends and demonstrates a steady increase over the study period.
Figure 3 shows the rates of test publication and test review during
the day, split between weekday and weekend. A peak of activity in test
publication is noted at midday. The weekend test publication pattern
could represent a similar pattern with a smaller midday peak.
Of the test results that were published, 7.69% (N¼136 175)
were subsequently reassigned to another patient record during a du-
plicate record merge process, as described in the “Methods.” This
leaves 92.31% (N¼1 634 600) which were correctly assigned to the
canonical patient record at publication.
Summary of dependent measures
The time to view abnormal biochemistry and hematology test results
is shown in Figure 4. The distribution is heavily skewed with a me-
dian of 89.8 min (interquartile range 33.9–213.8 min). This median
has stayed constant during the study period (see Supplementary
Table S1). Over the 30-day period after each of the 1 770 775 abnor-
mal biochemistry and hematology test results were made available,
1 662 067 results were viewed on the digital platform (93.9%) with
the remaining 108 708 (6.1%) of all test results being unviewed at
30 days (Figure 4). An unknown proportion of these 108 708 test
results will have had clinical review of the paper copy. In the loga-
rithmic time plot in Figure 4, 3 behavioral regimes are observed (1)
a fast, exponential rise to a peak value at around 30 min, (2) an ex-
ponential decline between 30 min, and (3) a long tail with a small
second peak of test viewing activity at 24 h.
Detailed test result type
The 30 most frequently performed tests are shown in Figure 5 and a
qualitative difference is apparent between tests such as D-dimer, or
troponin I assays, which have a high clinical impact in the short term,
and tests such as ferritin, or vitamin B12 levels, abnormalities of which
have longer-term sequelae, and management. Both the speed and the
likelihood that a clinician is to review a result varies depending on the
test type. Correlation strengths are estimated with Cramer’s V coeffi-
cient19 for the relationship between test type and whether a result has
been viewed is 0.585. A Kruskal–Wallis20 test demonstrated a signifi-
cant difference between distributions of time to view (v2¼20476,
P<2.21016). Pairwise Wilcoxon tests21 demonstrated some corre-
lated test types, where the results of a test are frequently reported to-
gether (eg, Cal/alb ratio and corrected calcium).
Time of the week of test result publication
The rate at which tests are published and reviewed (Figure 4) dem-
onstrated a daily rhythm of the test request and review process.
Figure 1. At time point (1) a specimen and associated request starts being
processed at the laboratory. At (2) the result is made available on the elec-
tronic results system. The processing time (3) depends on various factors in-
cluding the type of test. After a period of time (4) a result may be viewed by
one or more clinicians—the “time to view.” Some results are not reviewed
digitally or reviewed very late (5) (30-day cut-off was applied)—these results
are deemed to be “unviewed.” Test results, however, may have been viewed
through parallel routes such as paper reports (eg, microbiology) (6) or second
dedicated systems (eg, radiology).
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The impact of this daily pattern on the time taken to view tests
and the likelihood a test is not viewed was investigated and the
results are shown in Figure 6. The density plot in the top panel has
notable features. From Monday to Friday, the bulk of test results are
viewed during the first six hours after becoming available, but the de-
lay in reviewing a test increased throughout the morning. A test re-
leased at midday took twice as long to be reviewed as those made
available at 6 AM (A). Through the afternoon and overnight, the delay
reviewing a result dropped again, but the chance of the test being
reviewed the following day increased (widening the interquartile
range of time to view) (B). On Friday, the pattern is slightly different
in that the results that became available in the afternoon and not seen
the same day were more likely to be viewed on Monday morning (C).
The variation of the median time to view over the week is shown
in the middle panel of Figure 7 for completeness as the linear plot
better demonstrates the effect size and the relative errors of our esti-
mates. It shows the increasing delay in test result viewing over the
course of the morning, recovering by mid-afternoon, followed by a
smaller second increase at the end of the afternoon as a proportion
of results were left until the next day.
The proportion of tests that are not viewed is shown in the bottom
plot of Figure 6. Tests conducted overnight when staffing levels were
low were more likely to be looked at than those in the middle of the day
(point D). As with the time to view, the chance of a test being missed in-
creased if it was released later in the afternoon during the week. The
most significant increase in unviewed tests occurred on Friday afternoon
when a released result has just under 10% chance of not being seen (E).
On the weekend the pattern was slightly different, with tests that were
performed in the middle of the day being less likely to be viewed (F).
Test result reassignment
As described in the “Methods” above, test result reassignment may
be an indication that a test result was difficult to find and less likely
to be reviewed. The patient identifier was revised in 136 177 out of
1 770775 of test results (7.69%) of which only 2386 (1.78%) repre-
sented revision to a completely different patient, for example, due to
error ordering or processing the test. The remainder was revisions to a
different identifier of the same patient and represents a data quality is-
sue encountered during integration of new test results. Although this
had only a small effect on the time to view the results, there was a sig-
nificant effect on the proportion of results not viewed, with an addi-
tional 4% of the revised tests not being looked at within 30 days,
compared to those which are not revised (see Figure 7).
DISCUSSION
Principal findings
For inpatients within TSFT, blood tests are typically performed dur-
ing admission and throughout the patient’s stay as determined by
the clinical team. Dedicated phlebotomists generally pick up
requests, and draw blood for blood tests during the early part of the
morning on both weekdays and a limited service at weekends. These
will usually not be urgent test requests, and the request for the test
may have been made the night before. If an urgent test is required
blood will be drawn by a member of the clinical team. This system
explains the morning peak in the volumes of tests pattern shown in
Figure 3 when a high proportion of test results will be from routine
requests.
Typically, particularly for general inpatients, the clinical team
will conduct a ward round during the morning during which they
will review patients, including the available blood test results if pos-
sible. This ward round is largely conducted using paper notes, and
during this time the clinical team has variable access to desktop PC
bound resources, including the laboratory test review software.
Ward rounds generally finish during the course of the morning, after
which the junior members of the clinical team have better access to
digital systems.
Figure 2. The rate of abnormal biochemistry and hematology test results per
day during the study period.
Figure 3. Publish and view rates over the course of the day for test results, for
weekdays (A) and weekends (B).
Figure 4. The distribution of the time to view a result within the first 12 h of it
becoming available (grey) shows a heavily skewed distribution with a long
tail. The cumulative proportion of tests viewed is shown in red. Time is plot-
ted on a logarithmic scale.
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Test results may be reviewed by doctors, midwives, or any other
clinical staff caring for the patient. However, the bulk of the results re-
view, particularly of routinely requested tests from that day, will be
performed by the junior clinical staff, typically during the afternoon.
We believe that some of the increased delay in test result review in the
middle of the day seen in Figures 3 and 6 is a result of the limited ac-
cess that junior members of the clinical team have to the results plat-
form during the ward round. Seriously abnormal results may be
phoned through to ward staff, who will then alert a clinician to the re-
sult, who in turn will typically review the patient’s results.
Outside of weekday working hours, the hospital runs a shift sys-
tem for clinical staff.22 This will typically involve a handover of clin-
ical care around 5 PM to an evening shift, and again at
approximately 10 PM to an overnight shift. In general, these teams
will only be involved with acutely sick patients and will not consider
routine test results. This handover of responsibility, and shift away
from routine, to urgent care, is likely to be the main driver for the in-
creased delay for test results that are published later in the day seen
in Figure 6.
The possibility of a strong effect of routine versus urgent testing
on both completeness and timeliness of test result review is sup-
ported by the analysis of detailed test type shown in Figure 5. Tests
for significant acute medical conditions such as D-dimer tests for
thrombosis, or troponin tests for myocardial infarction, are more
rapidly and completely reviewed than tests that are long term in na-
ture, such as investigations for iron deficiency anemia. One possible
conclusion is that investigation of longer-term health problems in
inpatients is less efficient than the investigation of an acute health
problem, but this also points to some prioritization of clinical review
of test results that are urgent in nature.
Finally, this study found evidence in Figure 7 that data quality
has a significant effect on the result review, in that test results which
Figure 5. Time to view distribution (top), median time to view (middle), and proportion unviewed (bottom) for the 30 most common tests. The top violin plot
shows the distribution of time to view in the first 30 days from publication on a logarithmic timescale, for each test. In the middle plot, the same median is shown
with 95% confidence intervals for the median calculated using a bootstrap estimation. In the lower plot, the absolute proportion of tests that are unviewed is
shown with 95% confidence intervals determined by the size of the group, assuming a binomial distribution.
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have had to be reassigned to a duplicate patient identifier during a
merge, were less likely to be reviewed. This is evidence that efforts
should be directed at not only improving data quality, but also that
further work is needed to understand what mitigations need to be in
place for finding hard to identify and temporary patient records.
Limitations
This study has several drawbacks due to the nature of information
available and quality of some fields in the source database. Particu-
larly information about the identity of test requesters reviewers was
not well standardized, and neither was information about the pre-
cise location of ordering and reviewing results.
As a retrospective observational data study we were unable to col-
lect hard data about the workflow of test requesting, sample collec-
tion, test reviewing, and clinical ward rounds. Instead all the
assumptions about the nature of the workflow have been reviewed for
accuracy by 6 independent TSFT staff, consisting of both frontline
clinicians and members of the digital implementation team in TSFT
involved in the deployment and maintenance of the digital test result
platform.
Evidence suggests that there is a strong effect of the patient’s ad-
mission and discharge on the timeliness and completeness of test re-
Figure 6. Time to view distribution (top), median time to view (middle), and proportion unviewed (bottom) for the tests with relation to the time of the week.
Darker colors of the top plot represent higher number of tests released at a given time of the week and how those are distributed over the time taken to view
them. The blue lines showing the median (solid) and interquartile ranges (dashed) of time to view on a logarithmic timescale. The banding pattern represents
results being reviewed on subsequent days. In the middle panel the same median time to view is shown in a linear time plot with very narrow 95% confidence
intervals estimated using bootstrapping. The bottom plot shows the percent of tests that are not viewed, broken down by when they are published. We see high
rates of test review at point (A), for test results published at midday on Monday. Results published later in the day may not be seen until the following day (B).
This effect is more pronounced on Friday where results may not be seen until the following Monday (C). Tests are most likely to be viewed if they are published
early on Tuesday (D) and least likely to be viewed if they are published on Friday evening (E) or during the day in the weekend (F).
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sult review.6–10 A linked patient admission, discharge, and transfer
dataset was not available and so this study is unable to confirm pre-
vious findings about the significance of tests that are pending at dis-
charge.5,7–9 As patient discharge typically occurs in the later part of
the day, a strong relationship to patient discharge could indirectly
explain some of the observed patterns. This would warrant investi-
gation as one possible confounder for the temporal patterns ob-
served. Ineffective follow-up of test results pending at discharge has
previously been shown to be a cause of diagnostic delay,2,6 but as
this was not available for analysis it should be a focus of further
work.
As indicated in Figure 1, the digital review of test results is not
the only mechanism through which results are viewed. Biochemistry
and hematology results are printed on paper, delivered to requesting
location, where the paper results may be reviewed, but these are sub-
sequently shredded and not filed in the patient record. Paper-based
review is quite variable across the hospital and is not recorded, but
it should be expected that the estimate of unviewed tests presented
here was at the upper end of the true value. Similarly, a test result
can be clicked but not actually reviewed due to some distraction in
practice, or a test result may need to be viewed multiple times to
complete the review process.
Because of issues associated with parallel review processes we
did not consider microbiology and radiology test results in our anal-
ysis. The complexity of result review in microbiology is described by
Bruins et al23 and this analysis focused on the simpler problem of
biochemistry and hematology test results. However, many of the
examples in the literature that describe the clinical impact of missed
test results focus on microbiology and radiology5,9 and hence this
reduces the comparability of our findings to previous studies.
Viewing a test result does not imply that appropriate clinical ac-
tion has been taken, or that the viewing clinician has taken responsi-
bility for follow-up. There were no clinical outcomes outside of lab
results available in our dataset; investigation was conducted to see
whether repeat testing could be used as a marker for clinical action
as in Lin and Moore,24 but this was uninformative. It has not been
possible to follow-up on the clinical significance of abnormal test
results, and there is no simple way to determine whether an
unviewed test could have affected the outcome, and whether an
unviewed test result itself would have provided useful information
to a clinical decision-making process.
Suggestions for improvement
It is to be expected that many of these findings, particularly around
workflow, are specific either to TSFT itself or to hospitals in the Na-
tional Health Service (UK). However, the findings suggest some im-
provement can be made in the efficiency of test review:
1. The competing demands for a clinician’s attention during the
morning ward round and potential difficulty accessing a static
desktop PC bound resource while at the bedside could be im-
proved by providing access to test results as soon as they become
available through mobile devices.
2. Test ordering and review systems should consider differentiating
between urgent and routine requests in both alerting the clinician
of the availability of a result and informing them of unexpected
abnormality.
3. Further technical measures could be adopted to better alert clini-
cians to abnormal results at times of the day when test are likely
to be missed, for example, by more proactive alerting clinicians
to abnormal results on Friday afternoons, or by requiring man-
datory sign off of abnormal results.12
4. Further improvement might be expected if the clinical review
software was enhanced to allow better handover of clinical re-
sponsibility for review of abnormal test results between clini-
cians working different shifts. Suboptimal transfer of care
between shift working teams within the hospital has previously
been identified as an area of high risk.25–27
5. Improvements in patient record search prior to test ordering
may improve data quality. This may reduce the number of tests
reported under suboptimal duplicate patient records and which
are subsequently lost in the system. However, better search for
temporary records in the result viewing platform is also war-
ranted.
6. Test result review would be more efficient if fewer results were
pending during the clinical ward rounds. This might be achieved,
for example, by changing the timing of the phlebotomy ward
rounds to ensure results are available before clinical ward
rounds.
7. Spikes in the rates of unviewed tests observed at the weekend
could represent abnormalities in routine monitoring tests
requested by the regular team, which are not being picked up by
the weekend team, whose focus is on urgent care. These tests are
arguably of low clinical value. A focus on appropriate test
requesting at the weekends may be indicated.
Figure 7. Time to view distribution (top), median time to view (middle), and
proportion unviewed (bottom) for the tests that have had their patient identi-
fier changed versus those that retain their original patient identifier. Tests
that have been updated and rematched to a “better” patient record are less
likely to be viewed. 95% confidence intervals are shown on the graph. P-val-
ues for both comparisons are smaller than numerical precision of the calcu-
lating software due to the large numbers of tests involved.
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CONCLUSIONS
This study presents a detailed analysis of a large sample of electronic
test results. The volume enables a closer look at workflow patterns
during the day than has been presented previously, and this shows
several patterns which are thought to be related to whole system
workflow, information availability and handover of clinical respon-
sibility, which have not, to our knowledge, been demonstrated be-
fore in the literature. To some degree the effect of shift handover
may be explained by a transition from urgent to routine care, as pre-
viously described.28
The study identifies that the data quality of the patient record
can influence the ease of locating a test result and increase the likeli-
hood that a result will go unreviewed. This is a novel finding that is,
so far, specific to TSFT but which would be useful to validate in an-
other setting. Taken together these findings allow the recommenda-
tion of various changes to the systems and workflow of test review
in TSFT as outlined above and the authors believe these are of rele-
vance to other hospitals.
TSFT is in the process of implementing a mobile device-based
pathology results viewer. The effect of this intervention on the work-
flow factors presented here may be significant as test results will be
more easily available, and this will be monitored using this study as
a baseline. We anticipate the recommendations presented in this
study will inform future technical development and implementation
of test result review platforms.
This is a retrospective observational study of a single site and our
conclusions are limited by this. It would be useful to repeat this
study in different hospitals to compare the results. It would be par-
ticularly valuable to look at a dataset that included the patient’s
admission, discharge, and transfer details to investigate the effect of
handover and tests pending at discharge better. This study is
designed to be a baseline to provide evidence for quality improve-
ment initiatives and technical enhancements to the laboratory test
reporting platform. Further studies should focus on periods before
and after such interventions to more rigorously test the improve-
ments suggested above.
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